We are delighted to find that the XRCC1 Arg194Trp and Arg399Gln polymorphisms are significantly associated with clinical outcomes in advanced lung cancer patients treated with platinum-based chemotherapy. The gene discussed is XRCC1; the disease is lung cancer.